| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/25/1996 | WO1996022292A1 Tricyclic vasopressin antagonists |
| 07/25/1996 | WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 07/25/1996 | CA2210632A1 Tricyclic benzazepine vasopressin antagonists |
| 07/24/1996 | EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/23/1996 | US5539128 Compounds for inhibiting leukotriene receptors as antiasmatics, antiarthritics, skin disorders, antiulcer agents or cardiovascular disorders |
| 07/23/1996 | CA1338484C 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996021435A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/18/1996 | WO1996008569A3 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209125A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/17/1996 | CN1126995A Antiallergic imidazoazepines |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536730 Imidazonaphthyridine derivatives |
| 07/16/1996 | CA2021338C Imidazoquinolone derivatives |
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020936A1 Novel thiazolidin-4-one derivatives |
| 07/11/1996 | WO1996020930A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | WO1996020702A1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome |
| 07/11/1996 | WO1996020690A2 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/11/1996 | CA2208844A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | CA2184174A1 Novel thiazolidin-4-one derivatives |
| 07/10/1996 | EP0635012B1 Unbridged bis-aryl carbinol derivatives, compositions and methods of use |
| 07/10/1996 | CN1126470A Pyridazinone derivatives with pharmaceutical activity |
| 07/10/1996 | CN1126468A Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 07/10/1996 | CN1126203A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 07/10/1996 | CN1126201A Fullfluoralkyl-substituted bezoylguanidine, preparation, parmaceuticle use of same and pharmaceutical containing same |
| 07/09/1996 | US5534525 Lactam derivatives |
| 07/09/1996 | CA2099381C Imidazopyridine paf/h _antagonists |
| 07/09/1996 | CA1338438C Pharmaceutical composition |
| 07/04/1996 | WO1996020281A1 Human phosphodiesterase type ivc, and its production and use |
| 07/04/1996 | WO1996020278A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof |
| 07/04/1996 | WO1996020193A1 Compounds and methods |
| 07/04/1996 | WO1996020159A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 07/04/1996 | WO1996020158A1 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds |
| 07/04/1996 | WO1996019990A1 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 07/04/1996 | CA2208501A1 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds |
| 07/04/1996 | CA2207820A1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | CA2182946A1 Human phosphodiesterase type ivc, and its production and use |
| 07/03/1996 | EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| 07/03/1996 | EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 07/03/1996 | EP0719551A2 Isolating aminoarginine and use to block nitric oxide formation in body |
| 07/03/1996 | EP0719549A1 Soft gelatine pharmaceutical dosage form containing a translucent gel |
| 07/03/1996 | EP0719548A1 Gelling agent for polyethylene glycol |
| 07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719253A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 07/03/1996 | EP0719156A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| 07/03/1996 | EP0472598B1 Dry powder inhalation device |
| 07/03/1996 | CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 07/02/1996 | US5532368 Xanthine derivatives with adenosine-antagonistic activity |
| 07/02/1996 | US5532366 Enzyme inhibitors |
| 07/02/1996 | US5532305 Hyaluronic acid and cationic polyacrylic acid copolymer for time release agents |
| 07/02/1996 | US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents |
| 07/02/1996 | US5532237 Intraocular for treatment of glaucoma |
| 07/02/1996 | US5532235 Tricyclic benzazepine vasopressin antagonists |
| 07/02/1996 | US5532233 Platelet activating factor antagonist |
| 07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
| 06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 06/27/1996 | WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors |
| 06/27/1996 | WO1996019197A1 Aerosol formulations of peptides and proteins |
| 06/27/1996 | WO1996019183A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | CA2208772A1 Low molecular weight bicyclic thrombin inhibitors |
| 06/26/1996 | EP0717987A2 Suspension aerosol formulations |
| 06/26/1996 | EP0717624A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
| 06/26/1996 | CN1125445A Novel chemical compounds having PDE-IV inhibition activity |
| 06/26/1996 | CN1125442A Imidazole lipoxygenase inhibitors |
| 06/26/1996 | CN1125436A Vitamin D amide derivatives |
| 06/26/1996 | CN1125398A Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 06/26/1996 | CN1125231A Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 06/26/1996 | CN1125128A Method for preparation of Yanmei medicine |
| 06/26/1996 | CN1032135C 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(RS) derivatives with properties of mucus-adjustment and antiischemia |
| 06/25/1996 | US5530102 Methods and compositions for the direct concentrated delivery of passive immunity |
| 06/25/1996 | US5530009 Treating asthma |
| 06/25/1996 | US5529790 Delayed, sustained-release diltiazem pharmaceutical preparation |
| 06/25/1996 | CA2034934C Transdermal therapeutic system comprising tulobuterol as active substance |
| 06/25/1996 | CA2003692C Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract and additional applications for surfactant replacement therapy and other conditions requiring rapid phospholipid _absorption to surfaces |
| 06/20/1996 | WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 06/20/1996 | WO1996018399A1 Aryl thioxanthines |
| 06/20/1996 | WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 06/19/1996 | EP0717034A1 Vitamin D compounds and method of preparing these compounds |
| 06/19/1996 | CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists |
| 06/18/1996 | US5527827 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 06/18/1996 | US5527824 Substituted Di-T-Butlyphenols useful for inhibiting leukotriene synthesis |
| 06/15/1996 | CA2164916A1 Vitamin d compounds and method of preparing these compounds |
| 06/13/1996 | WO1996017863A1 Induction of cytotoxic t-lymphocyte responses |
| 06/13/1996 | WO1996017609A1 Use of 2-[4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma |
| 06/13/1996 | WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation |
| 06/13/1996 | CA2204738A1 Induction of cytotoxic t-lymphocyte responses |
| 06/13/1996 | CA2182904A1 Use of 2-[4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma |
| 06/12/1996 | EP0715853A1 Use of glutathione esters for the treatment of pulmonary diseases |
| 06/12/1996 | EP0715519A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 06/12/1996 | CN1124486A Heterocycle-containing amidine derivatives, their preparation and use |
| 06/11/1996 | US5525624 A 3-benzoyl,4-oxyphenylbenzothiophene compound |